The Executive Manager for Precision ALS will be responsible for coordinating the execution of the Precision ALS Project & work packages. The Executive Manager is responsible for achieving the programme objectives and will report to the Spoke Director, Prof. Orla Hardiman and will work directly with the Director and Executive Director at ADAPT (the Programme Host research centre), and with the Centre Directors (ADAPT, Future Neuro), the Business Development and the operations teams within the participating Centres. The role holder will drive the realisation of the PrecisionALS research programme and strategy and will be responsible for ensuring the coherency of the overall programme and the provision of a consistent interface to industry and enterprise partners, team members, researchers and the prime sponsor (SFI).
Precision ALS is a €10 million collaborative research programme involving researchers at the SFI Research Centres ADAPT and FutureNeuro along with the TRICALS Consortium, Europe’s largest ALS research initiative. National and International industry partners and charities including patient organisations are also actively participating.
Precision ALS will provide an innovative and interactive platform for all clinical research in ALS across Europe, that will then harness artificial intelligence (AI) to analyse large amounts of clinical and research data. The programme cements Ireland’s world leadership position in ALS research and Artificial Intelligence, and will generate scores of new jobs in clinical and data science research, new technologies and drug development for Ireland.
Precision ALS is a unique programme that brings together Clinicians, Computer Scientists, Information Engineers, Technologists, and Data Scientists. The researchers will work together with a number of companies including Biogen, Novartis, Takeda, IQVIA, Roche and Accenture to generate a sustainable precision medicine- based approach towards new drug development that will have many benefits including better clinical outcomes for patients and reducing the economic cost of these diseases.
On completion, Precision ALS will be a first-in-kind modular transferable pan-European ICT framework for ALS that can be easily adapted to other diseases that face similar precision medicine-related challenges.
The Executive Manager will drive the strategic planning and oversee the implementation of this newly established multi-million Euro research programme Precision ALS and will have the responsibility for achieving the research programme targets.
The project goal is to enable a data-driven and a precision medicine approach towards new drug development for neurodegenerative disease by combining applied clinical research with cutting edge data science.
The Programme is coordinated by Prof Orla Hardmian and Prof Vincent Wade and involves researchers from two SFI Research Centres: ADAPT, (the programme lead), and FutureNeuro.
The Executive Manager will be responsible for achieving the spokes targets and will support the Spokes Leadership Team and Spokes Directors in strategic planning. The role holder will be responsible for the representation of the PrecisionALS Research programme, realising opportunities and growth of the programme and responsible to ensure key objectives of the Spoke are met. The key responsibilities of the role include:
The role-holder will require the following knowledge, skills and attributes for successful performance in the role.
In order to assist the selection process, applicants should submit a Curriculum Vitae and a Cover Letter (1x A4 page) that specifically addresses the following points in their application.
Informal enquiries about this post should be made to Mr Declan McKibben, Executive Director (declan.mckibben@adaptcen